PER 3.57% 8.7¢ percheron therapeutics limited

Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2, page-32

  1. 1,068 Posts.
    lightbulb Created with Sketch. 499
    So curiosity got the better of me and I took Akki off ignore momentarily...

    Summary:
    • Me: if we're successful with the PIIb DMD trial, are we a chance for off-label use?
    • Akki: other indications haven't succeeded, why will this one be different?

    The deliberate misdirection away from a genuine question tells me all I need to know re motive; back on ignore.

    If any knowledgeable posters have some insight into the original question, I'm still curious.

    Cheers.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.003(3.57%)
Mkt cap ! $78.43M
Open High Low Value Volume
8.4¢ 8.7¢ 8.4¢ $72.99K 855.8K

Buyers (Bids)

No. Vol. Price($)
2 452608 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 398595 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.